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doi:10.1016/j.ejvs.2010.09.012Abstract Introduction: Messenger RNA (mRNA) changes in the small intestine in response to
acute mesenteric ischaemia (AMI) could offer novel diagnostic possibilities, but have not been
described. The aim was to characterize the mRNA response to experimental AMI.
Materials and methods: Twelve pigs underwent catheterisation of the superior mesenteric
artery with injection of polivinylalcohol embolisation particles or sodium chloride. Laparotomy
and intestinal tissue sampling were performed. Microarray analysis was performed using the
GeneChip whole porcine genome array.
Results: Seven down-regulated cellular pathways were associated with protein, lipid and
carbohydrate metabolism. Seventeen up-regulated pathways were associated with inflamma-
tory and immunological activity, regulation of extracellular matrix and decreased cellular
proliferation. Thrombospondin (THS), monocyte chemoattractant protein 1(MCP-1) and gap
junction alpha 1(GJA-1) were consistently up-regulated in all embolised pigs. Genes encoding
earlier proposed biomarkers for AMI were up-regulated, such as lactate dehydrogenase and
creatine kinase, or down-regulated, such as intestinal fatty acid binding protein and gluta-
thione S-transferase.
Conclusion: This study describes the intestinal tissue response on a gene expression level to
AMI. THS, MCP-1 and GJA-1 were consistently up-regulated by ischaemia, whereas earlier
proposed biomarkers for AMI were not. Gene expression may not be directly linked to the
use of the corresponding proteins as potential clinical biomarkers.
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282 T. Block et al.Intestinal ischaemia, in particular due to acute thrombo-
embolic occlusion of the superior mesenteric artery (SMA),
is associated with high total mortality, 81e93%.1,2 Even
experienced clinicians find it difficult to diagnose the
patients quickly enough to permit timely intestinal revas-
cularisation. There is no readily accessible and reliable
biochemical tool for diagnosis. An ideal biomarker should
be highly sensitive, and sufficiently specific for ischaemia
of the small-bowel and colon. Furthermore, it must retain
structural integrity through the portal circulation and the
liver metabolism to such an extent that it is measurable in
peripheral venous blood samples.3 Several plasma
biomarkers for intestinal ischaemia such as D-dimer,4e6
alpha-glutathione S-transferase,7 intestinal fatty acid
binding protein,8 D-lactate,9 alkaline phosphatase, crea-
tine kinase and lactate dehydrogenase10 have been
proposed. However, these markers lack sufficient accuracy
to become decisive tools in the early clinical management
of patients with suspected intestinal ischaemia.11 Plasma
L-lactate is a marker for severe illness and systemic fatal
hypoperfusion, and becomes moderately elevated late in
the course in patients with intestinal ischaemia.12 In an
experimental model, L-lactate was found to be significantly
elevated in peritoneal fluid, but not in plasma,13 which
might be explained by the liver’s capacity to clear large
quantities of lactate from the portomesenteric circula-
tion.14 Other proteins have been claimed to be specific for
intestinal tissue,15e18 or noted in models of cellular
ischaemia in other organs.19,20 These proteins could also be
of interest in detecting acute mesenteric ischaemia.
Our research group has previously described an exper-
imental model for inducing intestinal ischaemia by
occluding the SMA via the endovascular route with embo-
lisation particles, thus performing laparotomy only in the
end of the study for intestinal tissue sampling.13 This
minimally invasive model mimics the authentic situation of
acute SMA occlusion and avoids the surgical trauma asso-
ciated with laparotomy and bowel manipulation, which
can introduce a systematic bias in, among others, the
fibrinolytic and coagulation systems.21 Hence, we consid-
ered this animal model suitable to study the intracellular
responses in the ischaemic bowel. Assaying mRNA by
microarray technique gives valuable insight into the
intracellular response to various biological processes.22
There are now commercially available microarrays for
both human and animal specimens that can detect the
expression of up to 20e30,000 genes. Analysis of mRNA
can give insights into various biochemical processes, and
may be of value for further diagnostic studies of AMI. The
aim of this exploratory study was to analyse the changes in
gene expression in response to severe ischaemic injury to
all layers of the small-bowel, using a whole genome
porcine microarray, and data mining by both inductive and
deductive strategies.Materials and Methods
The study was approved by the Ethics Committee, Lund
University, and the care and handling of animals were in
accordance with National Institutes of Health guidelines;
permission number M-110-04.Animal selection
The experimental animal methodology is described in detail
in a previous publication.13 In brief, 12 Landrace male pigs
were anaesthetised and scheduled for endovascular inter-
vention with access from the right groin. After angiography
of the visceral arteries, a catheter was placed in the
proximal part of the SMA. Occlusion of the artery (n Z 6)
was then performed by the injection of polyvinyl alcohol
foam embolisation particles. The control group (n Z 6)
underwent the same surgical procedure, with the exception
that sodium chloride infusion was given instead of the
embolisation particles. After exactly 4 h of ischaemia (or
sham), full-wall biopsies were retrieved from the central
part of the small-bowel, that is, in the area of distribution
of the SMA, in all animals.
A certified pathologist, blinded to the performed inter-
ventions, performed all microscopic examinations and
graded the ischaemic lesions according to Chiu.23 The
control animals had no visible signs of small-bowel
ischaemia at laparotomy and showed no signs of ischaemia
on histological examination (rated 0e1 according to the
Chiu classification). The experimental animals showed signs
of advanced small-bowel ischaemia, such as extensive blue
cyanotic dilated small-bowel loops, both on visual inspec-
tion at laparotomy and on histological examination (rated 4
according to the Chiu Classification). Macroscopic and
histological images of ischaemic versus control tissues were
published previously in an article describing the experi-
mental model.13
RNA quality was assessed by RNA Integrity Number (RIN)
and an RIN  9 was considered satisfactory for inclusion.24
RNA quantity of at least 3.5 mg was required for proceeding
with expression analysis. On the basis of insufficient RNA
quality and/or quantity, three ischaemic and three control
pigs were excluded from microarray analysis.
Thus, three ischaemic and three control pigs were
eligible for microarray analysis.
Sample collection and preparation
Biopsies (3e5 mm) of the small-bowel wall were surgically
collected and submerged in RNAlater (Qiagen AB, Solna,
Sweden). RNAlater is a commercially available solution for
stabilisation of RNA in tissue, and it has been shown to be
suitable for expression microarrays.25 All tissue samples
were stored in 70 C until extraction and analysis. Total
RNA was extracted from 50 to 100 mg RNAlater stabilised
tissue with Trizol reagent (Invitrogen Ltd., Paisley, UK).
RNA quality and concentration were measured using an
Agilent 2100 Bioanalyzer (Agilent Technologies, Waldbronn,
Germany) and NanoDrop ND-1000, respectively (NanoDrop
Technologies, Delaware, USA).
Microarray chip and analysis
The chip used in this study is a porcine genome array
(Affymetrix Inc., Santa Clara, CA, USA, array no: 9000623)
that covers the whole porcine genome. The array contains
23,256 transcripts from 20,201 Sus scrofa genes (including
all internal controls, 23,973 transcripts in total). Each probe
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match and one mismatch). A probe set is a collection of
probe pairs that interrogates the same sequence.
Total RNA (3.5 mg) was processed following the Gen-
eChip Expression 30-Amplification Reagents One-cycle
complementary DNA (cDNA) synthesis kit according to the
manufacturer’s instructions (Affymetrix Inc., Santa Clara,
CA, USA) to produce double-stranded cDNA. This cDNA was
then used to generate biotin-targeted cRNA according to
the manufacturer’s instructions. Fifteen microgram of the
biotin-labelled cRNA was fragmented to strands between
35 and 200 bases in length, 10 mg of which was hybridised
onto the GeneChip porcine genome array overnight in
the GeneChip Hybridisation oven 6400 using standard
procedures.
The microarrays were washed and stained in a Gen-
eChip Fluidics Station 450. Scanning was carried out with
the GeneChip Scanner 3000, and image analysis was per-
formed. Scanned arrays were analysed in Affymetrix Gen-
eChip Operating Software (GCOS) v. 1.4 using global scaling
to target Signal 100.
The array expression data were analysed according to
intention to treat, by both inductive and deductive strat-
egies. In the deductive strategy, we searched the expres-
sion data for predetermined sets of genes, which define
certain well-known cellular pathways, using gene ontology
associations26 (see the Biostatistical analysis). Further-
more, we investigated specific genes for proteins that have
been proposed as potential biomarkers of mesenteric
ischaemia, proteins associated specifically with intestinal
tissue and proteins previously noted in models of cellular
response to ischaemia.
In the inductive strategy, we identified the most up-
regulated genes without any preconceived notion about
which genes would be of interest.
Validation of gene expression by PCR
Polymerase chain reaction (PCR) is the standard method for
validating microarray data.27 In this study, TaqMan real-
time PCR (Applied Biosystems, Foster City, USA) was used
for validation with beta-2 microglobulin (B2M) as an
internal control gene.28 Trends in fold change were
compared between PCR and microarray results.
Biostatistical analysis
Expression in experimental and control animals was
compared using pair-wise comparisons in GCOS26 in
a crosswise fashion (a total of nine comparisons between
six pigs). In the inductive analysis, genes were considered
regulated according to the following criteria: a signal value
equal or greater than 50,f a significant change (Increase or
Decrease Call) in nine out of a total of nine comparisonsg
and an average signal log ratio (SLR) of at least 1 (equal
to a Fold Change of 2) for increased genes, or less than or
equal to 1 (equal to a Fold Change of 2) for decreased
f A quantitative measure of the relative abundance of
a transcript.
g Experimental chip compared with control chip, a total of nine
comparisons (Wilcoxon’s signed-rank test).genes, was required. Among the up-regulated genes, we
defined a gene as highly up-regulated if it had an SLR of at
least 2 (meaning a fourfold increase or more in genetic
expression). In the deductive analysis, the separate gene
expressions were reported regardless of signal value, SLR or
number of comparisons.
Gene Ontology26 associations were used for the func-
tional analysis of the regulated genes. Gene Ontology
provides an association of the gene with a biological func-
tion such as a cellular type, a molecular function or a bio-
logical process. Through Gene Ontology database AmiGO,
the observed number of regulated genes associated with
a Gene Ontology term was compared with the random
expected number using Fisher’s exact test.
Nine of the 33 transcribed loci that were highly up-regu-
lated (SLR 2) were not previously annotated in the porcine
GeneBank. These were subjected to manual searches for
best alignment in the human genome using the nucleotide
BLAST (Basic Local Alignment Search Tool) (http://blast.
ncbi.nlm.nih.gov/Blast.cgi 100422).
Results
Deductive strategy
Gene expressions for previously proposed biomarkers were
analysed regarding fold change (Table 1). Lactate dehy-
drogenase and creatine kinase were up-regulated, whereas
intestinal fatty acid binding protein (I-FABP 2) and gluta-
thione S-transferase were down-regulated.
In the group of genes encoding for intestine-specific
proteins (Table 1), calmodulin displayed a decreased fold
change in 6/9 comparisons with an SLR of1.38. Calponin 2,
Calponin 1 and Surfactant protein A were increased in
4/9, 7/9 and 6/9 comparisons with an SLR of 1.94, 1.28 and
0.74, respectively. Myosin did not display a significant fold
change.
In the group of genes noted in previous studies of gene
expression in response to ischaemia (Table 1), uncoupling
protein 2 showed an increase in 2/9 comparisons with an
SLR of 0.144. Tissue factor was increased in 5/9 compari-
sons with an SLR of 2.59.
Inductive strategy
In the selected group of 57 down-regulated genes, we iden-
tified seven cellular pathways with enrichment analysis
(Table 2). These were associated with carbohydrate, lipid
and protein metabolism, cell adhesion and transporter
activity.
In the selected group of 157 up-regulated genes, we
identified 17 cellular pathways byenrichment analysis (Table
2). These were associated with inflammatory and immuno-
logical response, regulation of the extracellular matrix,
cellular taxis and regulation of cellular proliferation.
We identified 33 highly up-regulated genes with a fold
change >4 (Table 3). The nine genes that were previously
not annotated could not be linked to a specific biological
function using BLAST-search. The majority of the annotated
genes are involved in the inflammatory response and
regulation of the extracellular matrix.
Table 1 Deductive analysis of gene expression data. A negative fold change indicates a decreased expression activity of that
gene.
Probe set ID Gene symbol Common name Change in no of comparisons Avg SLR Fold change
Proposed potential biomarkers for AMI
Ssc.11123.1.A1_at LDH Lactate dehydrogenase-B (LDH-B) 6/9 1.20 2.30
Ssc.415.1.S1_at CKM Muscle creatine kinase 7/9 1.46 2.74
Ssc.16525.1.S1_at FABP2 Intestinal fatty acid binding protein 6/9 2.31 4.96
Ssc.8516.1.A1_at GSTA2 Glutathione S-transferase 9/9 2.37 5.16
Intestine-specific proteins
Ssc.936.1.S1_at CNN2 Calponin 2 4/9 1.94 3.84
Ssc.9013.S1_at CNN1 Calponin 1 7/9 1.28 2.43
Ssc.16719.1.A1_at CALM1 Calmodulin (CALM1) 6/9 1.09 2.13
Ssc.3675.1.A1_at CALM1 Calmodulin (CALM1) 6/9 1.38 2.60
Ssc.16321.1.A1_at LOC396904 Myosin 0/9 e e
Ssc.13776.1.S1_at e Surfactant protein A 6/9 0.74 1.67
Ischemic proteins
Ssc.174.1.S2_at UCP3 Uncoupling protein 3 0/0 e e
Ssc.174.1.S1_at UCP3 Uncoupling protein 3 0/0 e e
Ssc.16350.1.S1_at UCP2 Uncoupling protein 2 2/9 0.14 1.10
Ssc.19907.1.S1_at LOC396677 Tissue factor 5/0 2.59 6.02
Table 2 Enrichment results Pathways up- or down-regulated among the selected genes that show change in 9 of 9 comparisons
(57 down-regulated genes, 157 up-regulated genes).
Observed (O) Expected V O/E p-value
Down-regulated pathways
Lipidbinding 3 0.253 11.875 0.002
Exopeptidase activity 2 0.077 26.125 0.002
Transporter activity 3 0.322 9.330 0.003
Heterophilic cell adhesion 2 0.122 16.328 0.006
Sugar binding 2 0.138 14.514 0.008
Carbohydrate binding 2 0.138 14.514 0.008
Response to chemical substance 3 0.452 6.642 0.009
Up-regulated pathways
Response to wounding 11 1.260 8.733 0.000
Inflammatory response 9 0.902 9.979 0.000
Innate immune response 9 0.949 9.488 0.000
Extracellular matrix 6 0.762 7.874 0.000
Negative regulation of cell proliferation 5 0.560 8.932 0.000
Taxis 4 0.498 8.038 0.001
Chemotaxis 4 0.498 8.038 0.001
GTPase activator activity 2 0.078 25.723 0.002
Extracellular matrix structural constituent 3 0.280 10.718 0.002
Enzyme activator activity 3 0.295 10.154 0.003
Regulation of cell proliferation 5 1.026 4.872 0.003
GTPase regulator activity 2 0.093 21.436 0.003
Hs Integrin-mediated cell adhesion KEGG 3 0.420 7.145 0.007
Response to chemical substance 4 0.917 4.360 0.010
Actin binding 3 0.529 5.674 0.013
Cell adhesion molecule activity 3 0.606 4.947 0.018
Metalloendopeptidase activity 2 0.233 8.574 0.020
284 T. Block et al.
Table 3 Highly up-regulated genes. Genes with a fold change >4.
Probe set ID Gene
symbol
Gene title Fold
change
Ssc.942.1.S1_at e Transcribed locus, weakly similar to NP_985615.1 [Eremothecium gossypii] 5.82
Ssc.8562.3.A1_at CTGF Connective tissue growth factor (CTGF) 5.78
Ssc.8330.1.S1_at RGS5 Regulator of G-protein signalling 5 5.13
Ssc.7785.1.S1_at e MRNA, clone: THY010014H09, expressed in thymus 5.06
Ssc.7721.1.A1_at e Transcribed locus 5.58
Ssc.7641.1.S1_at e MRNA, clone:ITT010099D07, expressed in intestine 4.92
Ssc.7266.1.A1_at e Transcribed locus, strongly similar to XP_001055327.1 similar to Periostin
precursor (PN) (Osteoblast-specific factor 2) (OSF-2) [Rattus norvegicus]
6.45
Ssc.6918.1.A1_at ACSL4 acyl-CoA synthetase long-chain family member 4 4.79
Ssc.657.1.A1_at MCP-1 monocyte chemoattractant protein 1 10.48
Ssc.6531.1.A1_at e MRNA, clone: LNG010017G02, expressed in lung 7.26
Ssc.639.1.A1_at GEM GTP binding protein overexpressed in skeletal muscle 5.31
Ssc.6371.1.A1_at PRNP Prion protein (PRNP), mRNA 6.63
Ssc.3343.1.S1_at e Transcribed locus 5.06
Ssc.3139.1.A1_at RGS2 Regulator of G-protein signaling 2 (RGS2), mRNA 6.41
Ssc.26180.1.S1_at e Transcribed locus 5.21
Ssc.23801.1.S1_at RETN resistin 5.13
Ssc.22761.1.S1_at CFL2 cofilin 2 4.50
Ssc.21589.1.S1_at e MRNA, clone: LVRM10028H06, expressed in liver 5.43
Ssc.21096.1.S1_at e MRNA, clone:OVRM10079G03, expressed in ovary 9.00
Ssc.20515.1.S1_at e Transcribed locus, moderately similar to NP_001012039.1 growth factor-
containing fibulin-like extracellular matrix protein 1 (predicted)
[Rattus norvegicus]
4.35
Ssc.19640.1.A1_at e Transcribed locus, weakly similar to NP_036856.1 receptor, IgE,
high affinity I, alpha polypeptide [Rattus norvegicus]
4.06
Ssc.19629.1.A1_at e Transcribed locus, moderately similar to NP_036683.1 growth
response 1 [Rattus norvegicus]
5.66
Ssc.17313.2.S1_at e MRNA, clone: UTR010034E02, expressed in uterus 5.94
Ssc.17313.1.A1_at e Transcribed locus 6.23
Ssc.1674.1.A1_at GLUT-3 Glucose transporter type 3 5.78
Ssc.16013.1.S1_at MMP1 Mmp1 mRNA for matrix metalloproteinase
(type I collagenase) (EC 3.4.24.7)
6.68
Ssc.1555.1.A1_at e MRNA, clone: LVRM10064D11, expressed in liver 4.89
Ssc.14559.1.S1_at ANXA1 Annexin I 5.78
Ssc.12365.1.A1_at e MRNA, clone:OVRM10055G11, expressed in ovary 5.13
Ssc.10583.1.A2_at DSTN destrin 5.23
Ssc.10226.1.A3_at e MRNA, clone:OVRM10072B12, expressed in ovary 4.92
Ssc.10145.1.S1_at e MRNA, clone:OVR010030B04, expressed in ovary 5.62
Ssc.10132.1.S1_at e MRNA, clone: LVRM10028H06, expressed in liver 4.69
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Three genes with a consistent up-regulation in 9/9
comparisons were selected for validation: thrombospondin
(THS), monocyte chemoattractant protein (MCP-1) and gap
junction protein (GJA-1). All showed a pattern of expres-
sion consistent with the levels obtained using the micro-
array analysis (Fig. 1). Beta-2 microglobulin (B2M) also
showed a gene expression consistent with the microarray
results (Fig. 1).Discussion
The porcinemodel for intestinal ischaemia usedwas feasible
for whole genome expression array studies using the Affy-
metrix porcine array. The overall assay data from the boweltissue biopsies were analysed using our data enrichment
software, which correctly differentiated between sham-
operated and ischaemic animals. The group of down-regu-
lated pathways share a common functional feature in that
they contribute to minimising the metabolic rate, with the
result of conserving energy and reducing generation of toxic
metabolites.29e31 The up-regulated pathways are involved in
increased inflammatory and immunological response, nega-
tive regulation of cellular proliferation and regulation of the
extracellular compartment, which, in the ischaemic bowel,
is a most hostile environment. All these findings are consis-
tent with the pathophysiological process of ischaemia. The
highly up-regulated genes can be functionally grouped into
two sets: genes mediating the inflammatory process and
those regulating the extracellularmatrix. These findings give
valuable insights into the adaptive mechanisms of intestinal
tissue cells to AMI.
Figure 1 Validation of array data with qPCR. Comparisons of
fold change as measured by Affymetrix microarray or qPCR in
four selected genes.
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described in pigs with intestinal or cardiac ischaemia. THS
acts by inhibiting nitric oxide (NO)-mediated vasodilation,32
thus exacerbating ischaemia. GJA-1 has been described to
mediate contraction band necrosis33 and has been
described in a porcine ischaemic model.34 MCP-1 promotes
local inflammation by attracting polymorphonuclear white
blood cells, and is reported in a porcine cardiac ischaemic
model.35 This study expands on those previous findings by
demonstrating how the ischaemic insult is mediated by
simultaneously ongoing biological pathways.
Unfortunately, none of the highly up-regulated genes
was found to be tissue specific for the intestine. It is
noteworthy, however, that some of the highly up-regulated
genes encode proteins that already today have commer-
cially available antibodies for humans, but not for pigs.
Therefore, we could not perform a validation of the highly
up-regulated genes with analysis of the protein contents in
peripheral plasma. This needs to be addressed in further
studies on human subjects.
We could not identify a uniform increase in the genes
encoding for proposed biomarkers of AMI, nor in the genes
encoding for proteins previously regarded as being tissue
specific (Table 1). This could reflect the fact that the ability
to detect proteins in peripheral venous blood is mainly
dependent on other factors such as the intracellular
amount of protein, protein integrity and its ability to reach
the peripheral bloodstream through the liver metabolism in
the event of necrosis of the intestinal mucosa. Gene
expression analysis in this context could generate further
hypotheses but may not lead directly to the discovery of
novel biomarkers. Calponin 1 þ 2 and Surfactant protein A
were increased: It would be interesting to examine whether
this increased mRNA expression is reflected at the corre-
sponding plasma protein level. To date, however, there are
no antibodies available for detecting these proteins in
porcine peripheral blood.
Limitations of the study
Early investigators used dogs when studying intestinal
ischaemia,36 but, later, these experimental models were
abandoned, as dogs are extremely sensitive to intestinalischaemia and easily die during the experiments. The porcine
and human gastrointestinal tracts, as well as their vascular
anatomies, arevery similar,37 and, therefore, thepighasbeen
used in previous investigations into intestinal ischaemia.38,39
The cellular functions studied consist of fundamental
biochemical pathways identical in most mammal species and
may therefore be applicable in a human clinical setting.
However, as mentioned above, antigens of specific proteins
may vary significantly between the species, which makes it
difficult to translate the experimental findings directly to
a study design on humans. In this study, half of the tissue
samples failed to generate sufficient RNA of acceptable
quality, and therefore had to be excluded. As a result, the
number of the studied specimens was relatively small, only
three animals per group. However, in other microarray
studies, investigations on this number of animals are not
uncommon. Considering the exploratory, hypothesis gener-
ating, aim of this investigation, this limitation is not crucial.
The vast majority of the target sequences of microarray
models do not yet have biological annotations. This means
that many responses of the cell can be detected, but we
cannot yet put them in their proper context, which was
evident in analysing the group of highly up-regulated genes
(Table 3). Annotations are ongoing at an accelerated pace
and will increase the explanatory power of this type of
studies, thus contributing further to the understanding of
the cellular biochemistry of small-bowel ischaemia. Indeed,
in the near future, this specific study could generate further
important interpretations due to ongoing annotation.
Conclusions
This study gives detailed insight into the adaptive response
of the small-bowel wall to ischaemia. We found conflicting
results among genes encoding for proposed biomarkers of
AMI and for proteins thought to be intestinal tissue specific,
but this mRNA expression study of the small-bowel may
serve as a first stepping stone towards identifying a novel
biomarker of AMI.
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